Georgia Garinois-Melenikiotou Net Worth

The estimated Net Worth of Georgia Melenikiotou is at least $354 Thousand dollars as of 18 August 2021. Ms. Melenikiotou owns over 992 units of Inspire Medical Systems Inc stock worth over $28,924 and over the last 4 years she sold INSP stock worth over $325,520. In addition, she makes $0 as Director at Inspire Medical Systems Inc.

Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!

Sign up

Already have an account? Sign in

or

Sign up with Google Sign up with Facebook

Ms. Melenikiotou INSP stock SEC Form 4 insiders trading

Georgia has made over 3 trades of the Inspire Medical Systems Inc stock since 2020, according to the Form 4 filled with the SEC. Most recently she sold 566 units of INSP stock worth $120,117 on 20 August 2021.

The largest trade she's ever made was buying 26,315 units of Inspire Medical Systems Inc stock on 5 October 2020 worth over $499,985. On average, Georgia trades about 995 units every 11 days since 2020. As of 18 August 2021 she still owns at least 140 units of Inspire Medical Systems Inc stock.

You can see the complete history of Ms. Melenikiotou stock trades at the bottom of the page.

Georgia Garinois-Melenikiotou biography

Georgia Garinois-Melenikiotou serves as Director of the Company. Most recently, Ms. Garinois-Melenikiotou led Estée Lauder's global marketing function as Executive Vice President for Corporate Marketing where she was a member of Estee Lauder's Executive Leadership team. Ms. Garinois-Melenikiotou reported directly to the CEO and led the company's consumer insights, analytics, digital marketing, media, global customer care, local relevancy, and brand equity development centers of excellence across the world, and was instrumental in operationalizing the company's digital-first strategy and plan. Previously, she served in various senior marketing and management roles with increasing responsibility over a 26-year period at Johnson & Johnson and helped establish the company's global beauty business. As President of Beauty Global Business Unit Strategy and New Growth, Ms. Garinois-Melenikiotou was responsible for developing and implementing the unit's growth strategy and led global growth initiatives in priority emerging markets, new platforms, new beauty categories, and new channels. Ms. Garinois-Melenikiotou earned an MBA from the Massachusetts Institute of Technology. She received her Bachelor's and Master's degrees in Mechanical Engineering from the National Technical Institute of Athens.

What's Georgia Melenikiotou's mailing address?

Georgia's mailing address filed with the SEC is C/O INSPIRE MEDICAL SYSTEMS, INC., 5500 WAYZATA BLVD., SUITE 1600, GOLDEN VALLEY, MN, 55416.

Insiders trading at Inspire Medical Systems Inc

Over the last 7 years, insiders at Inspire Medical Systems Inc have traded over $616,949,559 worth of Inspire Medical Systems Inc stock and bought 1,156,150 units worth $18,512,150 . The most active insiders traders include & Johnson Johnson & Johnson..., Advisors Llc Orbi Med Capit..., and Chau Quang Khuong. On average, Inspire Medical Systems Inc executives and independent directors trade stock every 11 days with the average trade being worth of $10,091,170. The most recent stock trade was executed by Shawn Mc Cormick on 9 September 2024, trading 800 units of INSP stock currently worth $176,000.

What does Inspire Medical Systems Inc do?

inspire medical systems, inc. is a medical devices company based out of 9700 63rd avenue north suite 200, maple grove, minnesota, united states.

Complete history of Ms. Melenikiotou stock trades at Inspire Medical Systems Inc and Pulmonx Corp

Inspire Medical Systems Inc executives and stock owners

Inspire Medical Systems Inc executives and other stock owners filed with the SEC include:

• Timothy Herbert,
  President, Chief Executive Officer, Director
• Randall Ban,
  Chief Commercial Officer
• Richard Buchholz,
  Chief Financial Officer
• Timothy P. Herbert,
  CEO, Pres & Director
• Richard J. Buchholz,
  Chief Financial Officer
• Randall A. Ban,
  Chief Commercial Officer
• Philip J. Ebeling,
  Chief Operating Officer
• Steven L. Jandrich,
  VP of HR
• Gary Ellis,
  Independent Director
• Marilyn Nelson,
  Independent Chairman of the Board
• Shawn McCormick,
  Independent Director
• Casey Tansey,
  Independent Director
• Jerry Griffin,
  Independent Director
• Dana Mead,
  Independent Director
• Georgia Garinois-Melenikiotou,
  Director
• Shelley Broader,
  Director
• Steven Jandrich,
  Chief Compliance Officer, Vice President of Human Resources
• Philip Ebeling,
  Chief Operating Officer
• Andreas Henke,
  Sr. VP of European Operations
• Ivan Lubogo,
  Sr. VP of U.S. Sales
• Martin Abrams,
  VP of Marketing & Customer Experience
• Bryan K. Phillips,
  Sr. VP, Gen. Counsel, Chief Compliance Officer & Corp. Sec.
• John Rondoni,
  VP of Product Devel., Operations & Quality
• Myriam Curet,
  Director
• & Johnson Johnson & Johnson...,
  
• Chau Quang Khuong,
  Director
• Perkins Caufield & Byers Xi...,
  
• Advisors Llc Orbi Med Capit...,
  
• Mudit K. Jain,
  Director
• Joyce Erony,
  Director
• Life Science Partners L P S...,
  
• Management Group Ix, L.L.C....,
  
• Health Investors, Llc Kazma...,
  
• Inc Medtronic Plc Medtronic,
  
• Randy Ban,
  Chief Commercial Officer
• Bryan K Phillips,
  See Remarks
• Carlton Weatherby,
  Chief Strategy Officer
• John Rondoni,
  Chief Technology Officer
• Cynthia Burks,
  Director
• Charisse Y Sparks,
  Chief Medical Officer
• Melissa Mann,
  Chief People Officer